Table 1.
Case No. | Study [Ref.] | Age at diagnosis, years (sex) | Route | Dose | Duration | Outcomes |
---|---|---|---|---|---|---|
1 | Malviya et al. [11] | 40 (male) | Intravenous | 3 mg/kg/day in 2 divided doses | 5 days | Improvement of all lesions within 48 h Reduction of erythema and pain Dusky centres failed to progress Resultant hyperpigmentation at prior sites |
2 | Beniwal et al. [12] | 42 (male) | Unspecified | 5 mg/kg/day | Unspecified | Complete healing of lesions within 1 week No pigmentary change |
3 | Beniwal et al. [12] | 24 (male) | Unspecified | 5 mg/kg/day | Unspecified | Excellent response in 5–7 days Lesions healed with hypopigmentation |
4 | Daulatabadkar et al. [13] | 55 (male) | Oral | 100 mg per day | 7 days | After 14 days, patient recovered completely without any sequalae Complete re-epithelialization of skin Lesions healed with mild hyperpigmentation |
5 | Vargas Mora et al. [14] | 35 (female) | Oral | 5 mg/kg/day | 5 days | Cessation of blistering Lesions resolved with postinflammatory hyperpigmentation |